| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arabidopsis | 23 | 2016 | 97 | 2.980 |
Why?
|
| Humans | 68 | 2023 | 4119 | 2.400 |
Why?
|
| Sequence Analysis, DNA | 18 | 2021 | 249 | 2.240 |
Why?
|
| Mutation | 22 | 2022 | 608 | 2.220 |
Why?
|
| MicroRNAs | 10 | 2020 | 82 | 1.800 |
Why?
|
| Gene Silencing | 8 | 2013 | 30 | 1.670 |
Why?
|
| Genome, Plant | 14 | 2016 | 48 | 1.520 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2023 | 529 | 1.370 |
Why?
|
| Head and Neck Neoplasms | 3 | 2021 | 8 | 1.170 |
Why?
|
| Computational Biology | 10 | 2021 | 164 | 1.140 |
Why?
|
| Rare Diseases | 3 | 2021 | 9 | 1.110 |
Why?
|
| Circulating Tumor DNA | 2 | 2023 | 6 | 1.100 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 20 | 1.090 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2023 | 6 | 1.080 |
Why?
|
| Neoplasms | 7 | 2023 | 135 | 1.070 |
Why?
|
| Mutagenesis, Insertional | 3 | 2021 | 11 | 1.050 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2022 | 2 | 1.040 |
Why?
|
| Genetic Testing | 6 | 2023 | 66 | 1.010 |
Why?
|
| DNA Transposable Elements | 2 | 2021 | 12 | 0.960 |
Why?
|
| Software | 7 | 2021 | 133 | 0.920 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 312 | 0.920 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 4 | 0.920 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 10 | 0.910 |
Why?
|
| Algorithms | 9 | 2020 | 165 | 0.900 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 9 | 0.880 |
Why?
|
| Exome | 7 | 2022 | 124 | 0.870 |
Why?
|
| DNA Copy Number Variations | 2 | 2022 | 79 | 0.870 |
Why?
|
| Asthma | 1 | 2022 | 6 | 0.860 |
Why?
|
| Female | 19 | 2023 | 2147 | 0.830 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 3 | 0.820 |
Why?
|
| Mosaicism | 1 | 2020 | 9 | 0.750 |
Why?
|
| Embryonic Development | 1 | 2020 | 16 | 0.750 |
Why?
|
| Genomics | 9 | 2023 | 143 | 0.700 |
Why?
|
| Base Sequence | 13 | 2023 | 275 | 0.660 |
Why?
|
| Genome | 4 | 2018 | 77 | 0.630 |
Why?
|
| Alleles | 7 | 2022 | 221 | 0.610 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2022 | 173 | 0.600 |
Why?
|
| Chromosome Mapping | 7 | 2012 | 146 | 0.560 |
Why?
|
| Phenotype | 12 | 2021 | 479 | 0.550 |
Why?
|
| Genetic Variation | 7 | 2021 | 189 | 0.540 |
Why?
|
| Models, Genetic | 5 | 2018 | 117 | 0.530 |
Why?
|
| Oryza | 2 | 2013 | 12 | 0.530 |
Why?
|
| RNA, Plant | 5 | 2012 | 23 | 0.500 |
Why?
|
| Molecular Sequence Data | 13 | 2015 | 301 | 0.500 |
Why?
|
| Male | 17 | 2021 | 1811 | 0.490 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2020 | 4 | 0.490 |
Why?
|
| Precision Medicine | 3 | 2023 | 22 | 0.480 |
Why?
|
| Sequence Alignment | 3 | 2014 | 83 | 0.480 |
Why?
|
| Databases, Genetic | 6 | 2021 | 62 | 0.460 |
Why?
|
| Genetic Association Studies | 5 | 2019 | 122 | 0.450 |
Why?
|
| Sequence Deletion | 5 | 2019 | 51 | 0.440 |
Why?
|
| Loss of Function Mutation | 3 | 2022 | 29 | 0.420 |
Why?
|
| DNA Mutational Analysis | 6 | 2020 | 122 | 0.420 |
Why?
|
| Genes, Neoplasm | 3 | 2020 | 7 | 0.390 |
Why?
|
| Genome, Human | 7 | 2021 | 104 | 0.390 |
Why?
|
| Adult | 11 | 2023 | 944 | 0.390 |
Why?
|
| Machine Learning | 2 | 2021 | 27 | 0.370 |
Why?
|
| Transcriptome | 4 | 2020 | 201 | 0.370 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 58 | 0.370 |
Why?
|
| Arthrogryposis | 2 | 2021 | 9 | 0.360 |
Why?
|
| Pedigree | 9 | 2022 | 304 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 39 | 0.360 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2021 | 10 | 0.360 |
Why?
|
| Citrobacter | 2 | 2020 | 2 | 0.350 |
Why?
|
| Skin Neoplasms | 2 | 2022 | 10 | 0.350 |
Why?
|
| Genes, Plant | 9 | 2013 | 55 | 0.350 |
Why?
|
| DNA, Plant | 6 | 2011 | 25 | 0.350 |
Why?
|
| Polymorphism, Genetic | 6 | 2015 | 68 | 0.340 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 35 | 0.340 |
Why?
|
| Translocation, Genetic | 2 | 2021 | 41 | 0.340 |
Why?
|
| Animals | 10 | 2023 | 1545 | 0.340 |
Why?
|
| Epigenesis, Genetic | 3 | 2016 | 102 | 0.340 |
Why?
|
| Phylogeny | 6 | 2023 | 208 | 0.340 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2020 | 10 | 0.340 |
Why?
|
| DNA, Recombinant | 1 | 2008 | 5 | 0.330 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2023 | 48 | 0.320 |
Why?
|
| Chromosomes, Plant | 6 | 2016 | 18 | 0.320 |
Why?
|
| Cadherins | 2 | 2019 | 7 | 0.310 |
Why?
|
| Germ-Line Mutation | 3 | 2023 | 54 | 0.310 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2018 | 552 | 0.300 |
Why?
|
| Bayes Theorem | 3 | 2022 | 42 | 0.300 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 417 | 0.300 |
Why?
|
| Biomarkers | 3 | 2023 | 188 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 103 | 0.270 |
Why?
|
| Mutation, Missense | 2 | 2017 | 124 | 0.270 |
Why?
|
| Electronic Health Records | 2 | 2023 | 2 | 0.260 |
Why?
|
| Environment | 2 | 2017 | 12 | 0.260 |
Why?
|
| Haplotypes | 3 | 2022 | 122 | 0.260 |
Why?
|
| Genomic Structural Variation | 2 | 2016 | 2 | 0.260 |
Why?
|
| Genetic Heterogeneity | 3 | 2020 | 14 | 0.250 |
Why?
|
| Loss of Heterozygosity | 2 | 2021 | 12 | 0.250 |
Why?
|
| Child | 7 | 2023 | 557 | 0.250 |
Why?
|
| Epistasis, Genetic | 2 | 2014 | 19 | 0.250 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 92 | 0.250 |
Why?
|
| Arabidopsis Proteins | 4 | 2013 | 30 | 0.250 |
Why?
|
| Selection, Genetic | 6 | 2018 | 38 | 0.250 |
Why?
|
| Middle Aged | 8 | 2020 | 843 | 0.250 |
Why?
|
| DNA Methylation | 5 | 2018 | 186 | 0.240 |
Why?
|
| Proteins | 2 | 2017 | 77 | 0.240 |
Why?
|
| Fibroblasts | 2 | 2021 | 71 | 0.240 |
Why?
|
| Genotype | 7 | 2023 | 320 | 0.240 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2013 | 4 | 0.230 |
Why?
|
| Patients | 1 | 2023 | 1 | 0.230 |
Why?
|
| Advance Directives | 1 | 2023 | 1 | 0.230 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2023 | 1 | 0.230 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2023 | 1 | 0.230 |
Why?
|
| Health Level Seven | 1 | 2023 | 1 | 0.230 |
Why?
|
| Cystic Fibrosis | 2 | 2013 | 10 | 0.230 |
Why?
|
| Mansonella | 1 | 2023 | 3 | 0.230 |
Why?
|
| Sympatry | 1 | 2023 | 4 | 0.230 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 15 | 0.230 |
Why?
|
| Chronic Disease | 1 | 2023 | 20 | 0.230 |
Why?
|
| Parents | 2 | 2022 | 20 | 0.230 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2023 | 5 | 0.230 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 6 | 0.220 |
Why?
|
| Evolution, Molecular | 3 | 2020 | 114 | 0.220 |
Why?
|
| Cell Nucleus | 2 | 2020 | 36 | 0.220 |
Why?
|
| Mesothelioma | 1 | 2022 | 1 | 0.220 |
Why?
|
| Pleural Neoplasms | 1 | 2022 | 1 | 0.220 |
Why?
|
| Medical Oncology | 1 | 2022 | 5 | 0.220 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 3 | 0.220 |
Why?
|
| Optic Atrophy | 1 | 2022 | 5 | 0.220 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 6 | 0.220 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 11 | 0.220 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2022 | 6 | 0.220 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 13 | 0.220 |
Why?
|
| Hydrops Fetalis | 1 | 2022 | 1 | 0.220 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 3 | 0.220 |
Why?
|
| Carcinogenesis | 2 | 2021 | 17 | 0.220 |
Why?
|
| HLA-DQ Antigens | 1 | 2022 | 4 | 0.220 |
Why?
|
| United Kingdom | 1 | 2022 | 13 | 0.220 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 10 | 0.220 |
Why?
|
| HLA-DRB1 Chains | 1 | 2022 | 11 | 0.220 |
Why?
|
| Amino Acids | 1 | 2022 | 19 | 0.220 |
Why?
|
| Chemoradiotherapy | 2 | 2020 | 4 | 0.210 |
Why?
|
| Melanoma | 1 | 2022 | 13 | 0.210 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 148 | 0.210 |
Why?
|
| Oncogenes | 1 | 2021 | 3 | 0.210 |
Why?
|
| Genetics, Medical | 1 | 2021 | 4 | 0.210 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 21 | 0.210 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 1 | 0.210 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 31 | 0.200 |
Why?
|
| Information Dissemination | 1 | 2021 | 3 | 0.200 |
Why?
|
| Intersectoral Collaboration | 1 | 2021 | 2 | 0.200 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2021 | 8 | 0.200 |
Why?
|
| Urban Population | 1 | 2021 | 4 | 0.200 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2021 | 1 | 0.200 |
Why?
|
| Collagen Type VI | 1 | 2021 | 1 | 0.200 |
Why?
|
| Collagen Type I | 1 | 2021 | 2 | 0.200 |
Why?
|
| Collagen Type VII | 1 | 2021 | 2 | 0.200 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2020 | 25 | 0.200 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 16 | 0.200 |
Why?
|
| Metagenomics | 1 | 2021 | 11 | 0.200 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 13 | 0.200 |
Why?
|
| Confidentiality | 1 | 2021 | 8 | 0.200 |
Why?
|
| Protein Isoforms | 1 | 2021 | 37 | 0.200 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 12 | 0.200 |
Why?
|
| NF-kappa B | 1 | 2021 | 26 | 0.200 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2021 | 18 | 0.200 |
Why?
|
| Datasets as Topic | 1 | 2021 | 16 | 0.200 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 56 | 0.200 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2011 | 26 | 0.200 |
Why?
|
| Myeloid Cells | 1 | 2021 | 31 | 0.200 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 60 | 0.200 |
Why?
|
| Contig Mapping | 1 | 2020 | 2 | 0.200 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 25 | 0.200 |
Why?
|
| Homozygote | 2 | 2018 | 117 | 0.200 |
Why?
|
| Silver-Russell Syndrome | 1 | 2021 | 39 | 0.200 |
Why?
|
| Ataxia | 2 | 2022 | 7 | 0.190 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 5 | 0.190 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 14 | 0.190 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 19 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 51 | 0.190 |
Why?
|
| Chromatin | 2 | 2018 | 49 | 0.190 |
Why?
|
| Genome, Bacterial | 2 | 2018 | 50 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 31 | 0.190 |
Why?
|
| Plasmids | 1 | 2020 | 27 | 0.190 |
Why?
|
| Rectum | 1 | 2020 | 2 | 0.190 |
Why?
|
| Aged | 5 | 2023 | 580 | 0.190 |
Why?
|
| Multimodal Imaging | 1 | 2020 | 1 | 0.190 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 3 | 0.190 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2020 | 2 | 0.190 |
Why?
|
| Genes, p53 | 1 | 2020 | 8 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 43 | 0.190 |
Why?
|
| Neurons | 1 | 2020 | 78 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 7 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 70 | 0.190 |
Why?
|
| Feces | 1 | 2020 | 31 | 0.190 |
Why?
|
| Microbiota | 1 | 2021 | 79 | 0.190 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2020 | 1 | 0.180 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2020 | 1 | 0.180 |
Why?
|
| STAT5 Transcription Factor | 1 | 2020 | 5 | 0.180 |
Why?
|
| Disease Outbreaks | 2 | 2021 | 13 | 0.180 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2019 | 1 | 0.180 |
Why?
|
| Cladribine | 1 | 2019 | 1 | 0.180 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2019 | 1 | 0.180 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2019 | 2 | 0.180 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 4 | 0.180 |
Why?
|
| Codon, Nonsense | 1 | 2020 | 54 | 0.180 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 19 | 0.180 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2019 | 1 | 0.180 |
Why?
|
| Web Browser | 1 | 2019 | 1 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2021 | 256 | 0.180 |
Why?
|
| Bryopsida | 2 | 2010 | 7 | 0.180 |
Why?
|
| Frameshift Mutation | 2 | 2010 | 32 | 0.180 |
Why?
|
| Gene Expression Regulation, Plant | 4 | 2013 | 86 | 0.170 |
Why?
|
| Arthritis, Juvenile | 1 | 2019 | 2 | 0.170 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 98 | 0.170 |
Why?
|
| Germany | 4 | 2023 | 251 | 0.170 |
Why?
|
| Adolescent | 5 | 2021 | 493 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 32 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 50 | 0.170 |
Why?
|
| Disease | 1 | 2018 | 6 | 0.170 |
Why?
|
| Intellectual Disability | 2 | 2017 | 122 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2018 | 13 | 0.170 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 28 | 0.170 |
Why?
|
| Uniparental Disomy | 1 | 2018 | 19 | 0.170 |
Why?
|
| DNA Replication Timing | 1 | 2018 | 2 | 0.170 |
Why?
|
| DNA Repair | 1 | 2019 | 60 | 0.170 |
Why?
|
| INDEL Mutation | 3 | 2018 | 12 | 0.170 |
Why?
|
| Cell Division | 1 | 2018 | 22 | 0.170 |
Why?
|
| Colistin | 1 | 2018 | 1 | 0.160 |
Why?
|
| Recombination, Genetic | 2 | 2009 | 26 | 0.160 |
Why?
|
| RNA, Messenger | 3 | 2015 | 263 | 0.160 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 139 | 0.160 |
Why?
|
| Drosophila | 2 | 2021 | 15 | 0.160 |
Why?
|
| Pseudomonas putida | 1 | 2017 | 1 | 0.160 |
Why?
|
| Infant | 4 | 2021 | 267 | 0.160 |
Why?
|
| Genes, Lethal | 1 | 2017 | 3 | 0.160 |
Why?
|
| Microfilament Proteins | 2 | 2014 | 17 | 0.150 |
Why?
|
| Craniosynostoses | 1 | 2017 | 8 | 0.150 |
Why?
|
| Plant Proteins | 3 | 2012 | 82 | 0.150 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 44 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 74 | 0.150 |
Why?
|
| Syringomyelia | 1 | 2016 | 1 | 0.150 |
Why?
|
| Aging | 1 | 2018 | 92 | 0.150 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2016 | 2 | 0.150 |
Why?
|
| Inflammation | 1 | 2018 | 179 | 0.150 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 7 | 0.150 |
Why?
|
| Plant Leaves | 3 | 2013 | 36 | 0.150 |
Why?
|
| Metabolomics | 1 | 2016 | 24 | 0.150 |
Why?
|
| Fragile X Syndrome | 1 | 2016 | 1 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2017 | 101 | 0.150 |
Why?
|
| Genetic Therapy | 1 | 2016 | 13 | 0.140 |
Why?
|
| Chromosome Inversion | 1 | 2016 | 1 | 0.140 |
Why?
|
| Down Syndrome | 1 | 2016 | 10 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 29 | 0.140 |
Why?
|
| Cognition | 1 | 2016 | 29 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2016 | 23 | 0.140 |
Why?
|
| Mice | 4 | 2021 | 737 | 0.140 |
Why?
|
| Sezary Syndrome | 1 | 2016 | 1 | 0.140 |
Why?
|
| Hybridization, Genetic | 2 | 2014 | 18 | 0.140 |
Why?
|
| Whole Genome Sequencing | 3 | 2021 | 27 | 0.140 |
Why?
|
| Calcium Channels, N-Type | 1 | 2015 | 1 | 0.140 |
Why?
|
| Genetic Fitness | 2 | 2014 | 5 | 0.140 |
Why?
|
| Mitral Valve Prolapse | 1 | 2015 | 1 | 0.140 |
Why?
|
| Transformation, Genetic | 2 | 2013 | 3 | 0.140 |
Why?
|
| Essential Tremor | 1 | 2015 | 5 | 0.130 |
Why?
|
| Oligodendroglia | 1 | 2015 | 8 | 0.130 |
Why?
|
| Plants, Genetically Modified | 2 | 2013 | 15 | 0.130 |
Why?
|
| Germ Cells | 1 | 2015 | 30 | 0.130 |
Why?
|
| Axons | 1 | 2015 | 12 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 33 | 0.130 |
Why?
|
| Pseudomonas Infections | 1 | 2015 | 3 | 0.130 |
Why?
|
| Protein Kinases | 1 | 2015 | 11 | 0.130 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2014 | 1 | 0.130 |
Why?
|
| TRPC Cation Channels | 1 | 2014 | 1 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 13 | 0.130 |
Why?
|
| Collagen Type IV | 1 | 2014 | 2 | 0.130 |
Why?
|
| Actinin | 1 | 2014 | 3 | 0.130 |
Why?
|
| Autoantigens | 1 | 2014 | 12 | 0.130 |
Why?
|
| Nephrotic Syndrome | 1 | 2014 | 8 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 3 | 2016 | 90 | 0.130 |
Why?
|
| Gene Frequency | 3 | 2009 | 120 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 210 | 0.130 |
Why?
|
| Myxococcus xanthus | 1 | 2014 | 1 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 99 | 0.130 |
Why?
|
| Research | 1 | 2014 | 9 | 0.120 |
Why?
|
| Proteome | 3 | 2021 | 57 | 0.120 |
Why?
|
| Gene Conversion | 1 | 2013 | 3 | 0.120 |
Why?
|
| Crossing Over, Genetic | 1 | 2013 | 4 | 0.120 |
Why?
|
| Meiosis | 1 | 2013 | 8 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2021 | 378 | 0.120 |
Why?
|
| Biological Evolution | 2 | 2014 | 86 | 0.120 |
Why?
|
| Gene Duplication | 2 | 2016 | 24 | 0.120 |
Why?
|
| Genomic Library | 1 | 2013 | 4 | 0.120 |
Why?
|
| Biopterin | 1 | 2013 | 1 | 0.120 |
Why?
|
| Phenylketonurias | 1 | 2013 | 1 | 0.120 |
Why?
|
| Epithelial Sodium Channels | 1 | 2013 | 1 | 0.120 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2013 | 4 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2023 | 186 | 0.110 |
Why?
|
| Sterols | 1 | 2012 | 1 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 16 | 0.110 |
Why?
|
| Esters | 1 | 2012 | 2 | 0.110 |
Why?
|
| Phytophthora infestans | 1 | 2012 | 3 | 0.110 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 64 | 0.110 |
Why?
|
| Response Elements | 1 | 2012 | 2 | 0.110 |
Why?
|
| Ribonuclease III | 2 | 2023 | 9 | 0.110 |
Why?
|
| Pseudohypoaldosteronism | 1 | 2012 | 1 | 0.110 |
Why?
|
| Sodium Chloride Symporters | 1 | 2012 | 2 | 0.110 |
Why?
|
| Nephrons | 1 | 2012 | 2 | 0.110 |
Why?
|
| Ion Transport | 1 | 2012 | 3 | 0.110 |
Why?
|
| Fetus | 2 | 2022 | 9 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2021 | 191 | 0.100 |
Why?
|
| Young Adult | 3 | 2021 | 345 | 0.100 |
Why?
|
| Nucleotides | 1 | 2011 | 8 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2012 | 65 | 0.100 |
Why?
|
| Linkage Disequilibrium | 2 | 2011 | 92 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2021 | 261 | 0.100 |
Why?
|
| Genetics, Population | 1 | 2011 | 46 | 0.100 |
Why?
|
| Zea mays | 1 | 2012 | 115 | 0.100 |
Why?
|
| Leukocytes | 2 | 2021 | 22 | 0.090 |
Why?
|
| Retroelements | 1 | 2009 | 10 | 0.090 |
Why?
|
| beta-Lactamases | 2 | 2020 | 6 | 0.090 |
Why?
|
| Siblings | 2 | 2020 | 28 | 0.090 |
Why?
|
| Risk Factors | 2 | 2021 | 265 | 0.090 |
Why?
|
| Plants | 1 | 2010 | 43 | 0.090 |
Why?
|
| DNA | 1 | 2009 | 102 | 0.090 |
Why?
|
| Brain | 2 | 2023 | 153 | 0.090 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2009 | 3 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 32 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2020 | 174 | 0.080 |
Why?
|
| Binding Sites | 3 | 2015 | 73 | 0.080 |
Why?
|
| Cell Movement | 2 | 2021 | 45 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2021 | 47 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2021 | 96 | 0.080 |
Why?
|
| Haploidy | 2 | 2020 | 10 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2020 | 51 | 0.080 |
Why?
|
| Natural Language Processing | 1 | 2006 | 1 | 0.070 |
Why?
|
| MEDLINE | 1 | 2006 | 1 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 133 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2006 | 8 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 9 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2006 | 21 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2021 | 27 | 0.070 |
Why?
|
| Base Pairing | 1 | 2006 | 9 | 0.070 |
Why?
|
| Genetic Loci | 2 | 2019 | 120 | 0.070 |
Why?
|
| Zebrafish | 2 | 2015 | 57 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 206 | 0.060 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 18 | 0.060 |
Why?
|
| Patient Care | 1 | 2023 | 3 | 0.060 |
Why?
|
| DNA, Ribosomal | 1 | 2023 | 13 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2023 | 3 | 0.060 |
Why?
|
| Exons | 2 | 2013 | 97 | 0.060 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2022 | 5 | 0.060 |
Why?
|
| Introns | 1 | 2023 | 60 | 0.060 |
Why?
|
| Genes, BRCA2 | 1 | 2022 | 5 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2022 | 1 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 1 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 3 | 0.060 |
Why?
|
| Breast | 1 | 2022 | 16 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2022 | 20 | 0.060 |
Why?
|
| Muscle Spasticity | 1 | 2022 | 5 | 0.060 |
Why?
|
| Multigene Family | 2 | 2013 | 30 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2022 | 6 | 0.050 |
Why?
|
| Prenatal Diagnosis | 1 | 2022 | 7 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 5 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 5 | 0.050 |
Why?
|
| Pregnancy | 1 | 2022 | 113 | 0.050 |
Why?
|
| Swine | 1 | 2021 | 11 | 0.050 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2021 | 1 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2021 | 7 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 38 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2021 | 10 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Comorbidity | 1 | 2021 | 18 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2021 | 28 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2021 | 14 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2021 | 19 | 0.050 |
Why?
|
| Family Health | 1 | 2021 | 24 | 0.050 |
Why?
|
| Europe | 1 | 2021 | 60 | 0.050 |
Why?
|
| Inbreeding | 2 | 2012 | 15 | 0.050 |
Why?
|
| Biodiversity | 1 | 2021 | 27 | 0.050 |
Why?
|
| COP9 Signalosome Complex | 1 | 2021 | 2 | 0.050 |
Why?
|
| Histocompatibility Antigens | 1 | 2021 | 3 | 0.050 |
Why?
|
| Quality Control | 1 | 2021 | 18 | 0.050 |
Why?
|
| Benchmarking | 1 | 2021 | 7 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 17 | 0.050 |
Why?
|
| Leukemia | 1 | 2021 | 37 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2021 | 149 | 0.050 |
Why?
|
| Protein Refolding | 1 | 2020 | 1 | 0.050 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2020 | 7 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2020 | 7 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 25 | 0.050 |
Why?
|
| Hospitals | 1 | 2020 | 4 | 0.050 |
Why?
|
| Cell Survival | 1 | 2020 | 45 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2021 | 261 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2020 | 50 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 7 | 0.050 |
Why?
|
| Cell Line | 1 | 2020 | 137 | 0.050 |
Why?
|
| Multilocus Sequence Typing | 1 | 2020 | 7 | 0.050 |
Why?
|
| Base Composition | 1 | 2020 | 14 | 0.050 |
Why?
|
| Bacterial Typing Techniques | 1 | 2020 | 16 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2020 | 15 | 0.050 |
Why?
|
| Fluorine Radioisotopes | 1 | 2020 | 1 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 1 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2020 | 2 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2020 | 3 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2021 | 322 | 0.050 |
Why?
|
| Receptor, Notch1 | 1 | 2020 | 6 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2020 | 16 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2020 | 25 | 0.050 |
Why?
|
| Genes, Bacterial | 1 | 2020 | 23 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 40 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 67 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 54 | 0.050 |
Why?
|
| COS Cells | 1 | 2020 | 18 | 0.050 |
Why?
|
| Triamcinolone | 1 | 2019 | 1 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 10 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 10 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2019 | 4 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 20 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 40 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 47 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 66 | 0.040 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 6 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 45 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 56 | 0.040 |
Why?
|
| Bias | 1 | 2018 | 4 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2018 | 24 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2018 | 17 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 345 | 0.040 |
Why?
|
| Chromosomes, Human | 1 | 2018 | 12 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 14 | 0.040 |
Why?
|
| MutL Proteins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 37 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 45 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2018 | 5 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 23 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 38 | 0.040 |
Why?
|
| Peptides | 1 | 2018 | 38 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 48 | 0.040 |
Why?
|
| Spinal Nerve Roots | 1 | 2017 | 1 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2017 | 16 | 0.040 |
Why?
|
| Biopsy | 1 | 2017 | 31 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2017 | 119 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2016 | 12 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2016 | 28 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2016 | 12 | 0.040 |
Why?
|
| Catechin | 1 | 2016 | 1 | 0.040 |
Why?
|
| Antioxidants | 1 | 2016 | 7 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 11 | 0.040 |
Why?
|
| Karyotyping | 1 | 2016 | 28 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2016 | 17 | 0.040 |
Why?
|
| Rats | 1 | 2016 | 164 | 0.040 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2016 | 1 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 26 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2015 | 11 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2016 | 57 | 0.030 |
Why?
|
| Calcium | 1 | 2015 | 42 | 0.030 |
Why?
|
| Cadherin Related Proteins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 4 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2015 | 6 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 11 | 0.030 |
Why?
|
| Body Patterning | 1 | 2015 | 14 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 31 | 0.030 |
Why?
|
| Inverted Repeat Sequences | 1 | 2015 | 2 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 5 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 2015 | 1 | 0.030 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2015 | 2 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2015 | 6 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 1 | 2015 | 3 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2015 | 7 | 0.030 |
Why?
|
| Environmental Microbiology | 1 | 2015 | 6 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 12 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2015 | 11 | 0.030 |
Why?
|
| TRPC6 Cation Channel | 1 | 2014 | 1 | 0.030 |
Why?
|
| Plant Physiological Phenomena | 1 | 2014 | 4 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2014 | 14 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 62 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 64 | 0.030 |
Why?
|
| Movement | 1 | 2014 | 4 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 161 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 138 | 0.030 |
Why?
|
| Epigenomics | 1 | 2014 | 24 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 27 | 0.030 |
Why?
|
| Abscisic Acid | 1 | 2013 | 2 | 0.030 |
Why?
|
| Gene Library | 1 | 2013 | 20 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 21 | 0.030 |
Why?
|
| Flowers | 1 | 2013 | 16 | 0.030 |
Why?
|
| Bronchiectasis | 1 | 2013 | 1 | 0.030 |
Why?
|
| Vas Deferens | 1 | 2013 | 1 | 0.030 |
Why?
|
| Infertility, Male | 1 | 2013 | 6 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2013 | 42 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 25 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 8 | 0.030 |
Why?
|
| Histone Code | 1 | 2012 | 4 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 2012 | 3 | 0.030 |
Why?
|
| Genes, Insect | 1 | 2012 | 3 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 12 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 14 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 18 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2012 | 10 | 0.030 |
Why?
|
| Protein Binding | 1 | 2012 | 97 | 0.030 |
Why?
|
| Seasons | 1 | 2012 | 8 | 0.030 |
Why?
|
| Reproduction | 1 | 2012 | 12 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2012 | 29 | 0.030 |
Why?
|
| Kidney | 1 | 2012 | 38 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 95 | 0.030 |
Why?
|
| Plant Roots | 1 | 2012 | 81 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 115 | 0.030 |
Why?
|
| Geography | 1 | 2011 | 14 | 0.030 |
Why?
|
| Longevity | 1 | 2012 | 40 | 0.030 |
Why?
|
| Centromere | 1 | 2011 | 8 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 47 | 0.020 |
Why?
|
| Deamination | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cytosine | 1 | 2010 | 8 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 8 | 0.020 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2009 | 1 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 14 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2009 | 6 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2009 | 6 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2009 | 13 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 97 | 0.020 |
Why?
|
| RNA Cleavage | 1 | 2009 | 1 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2009 | 11 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2009 | 9 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2009 | 44 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2009 | 14 | 0.020 |
Why?
|
| RNA Stability | 1 | 2009 | 36 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 13 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 20 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 93 | 0.020 |
Why?
|
| Vocabulary, Controlled | 1 | 2006 | 2 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 3 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2006 | 19 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2006 | 20 | 0.020 |
Why?
|
